L23.3 vs T81.82XS
L23.3 (Allergic contact dermatitis due to drugs in contact with skin) compared with T81.82XS (Emphysema (subcutaneous) resulting from a procedure, sequela), from the official CMS tabular data. Both may be reported when both conditions are documented (Excludes2).
Can these codes be reported together?
Yes, when both are documented. T81.82XS carries an Excludes2 note covering L23.3: “dermatitis due to drugs and medicaments (L23.3, L24.4, L25.1, L27.0-L27.1)”
Excludes2 marks distinct conditions — both may be reported when both are documented.
Side by side
| L23.3Allergic contact dermatitis due to drugs in contact with skin | T81.82XSEmphysema (subcutaneous) resulting from a procedure, sequela | |
|---|---|---|
| Billing status | Billable | Billable |
| Classification | L00-L99 — Diseases of the Skin and Subcutaneous Tissue (L00-L99) | S00-T88 — Injury, Poisoning and Certain Other Consequences of External Causes (S00-T88) |
| Definition | Allergic contact dermatitis due to drugs in contact with skin is a billable ICD-10-CM diagnosis code (L23.3). | Emphysema (subcutaneous) resulting from a procedure, sequela is a billable ICD-10-CM diagnosis code (T81.82S). |
| 7th character | — | The appropriate 7th character is to be added to each code from category T81 |
| Use additional code | code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5) | code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5) code(s) to identify the specified condition resulting from the complication code to identify devices involved and details of circumstances (Y62-Y82) |
Derived from the official CMS ICD-10-CM tabular data (FY2026). Not billing advice; verify sequencing rules for the encounter. All data sources